EGFR and neoplasm: It is worth mentioning that reprogramming TAMs can enhance the efficacy of EGFR-TKIs through a variety of mechanisms, including inhibition of TAM-related drug resistance pathway (34), reactivation of T cells in the TME (91), and reversal of EMT of tumor cells (104).